The long-awaited new drug application to the FDA for Cytisinicline has been completed. The countdown has begun to decision/approval and a potential 2.5-5x return for shareholders from current levels.
It's a negative headline, for sure but wirh the NDA in and accepted, I don't think it will be a problem. If this happened 2 months ago, it would have been very worrying.
Looks intriguing. Thanks for sharing this.
Curious if you have any comments after the recent selloff
Not exactly bullish https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-25-201418/achv-20250905.htm. What do you think?
It's a negative headline, for sure but wirh the NDA in and accepted, I don't think it will be a problem. If this happened 2 months ago, it would have been very worrying.
Thank you!